MBX Biosciences, Inc. (MBX) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mbx Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.280 -- 00:00:03.242 Good morning, everyone. Thanks for joining us. 00:00:03.242 -- 00:00:08.148 We have an update with Microbics focused on their Q3 00:00:08.148 -- 00:00:11.051 fiscal financials that they reported this morning. 00:00:11.051 -- 00:00:14.435 For those of you who have not seen them, you can find them on CEEDAR and I believe the 00:00:14.435 -- 00:00:18.940 website. As always, I don't believe we're going to work off a presentation today, but 00:00:18.940 -- 00:00:22.043 I promise to get an updated one on the website later today. 00:00:22.043 -- 00:00:26.629 But as always, this presentation will contain forward-looking statements. 00:00:26.629 -- 00:00:29.672 If you'd like to know more about those, you can find them on the presentation on the 00:00:29.672 -- 00:00:35.297 company's website. And with me today, I have Cameron Groom, CEO, 00:00:35.297 -- 00:00:40.384 Ken Hughes, COO, and Jim Curry, CFO. I think the format will be Cameron's going to 00:00:40.384 -- 00:00:44.389 do a bit of an overview on the quarter, and then we'll jump into Q&A and then have closing 00:00:44.389 -- 00:00:49.075 remarks. With all of that out of the way, Cameron, nice to see you. 00:00:49.075 -- 00:00:51.798 Thank you, Debra. Great to see you as well. 00:00:51.798 -- 00:00:56.224 And thank you, Ken and Jim also. This 00:00:56.224 -- 00:01:02.692 morning, we reported the results for our third quarter of fiscal 2025. 00:01:02.692 -- 00:01:08.318 That's the quarter ended June 30, 2025, and it was a 00:01:08.318 -- 00:01:13.444 weak quarter, our weakest in about three years due to lower 00:01:13.444 -- 00:01:19.251 sales to two clients, one to our distributor into China, 00:01:19.251 -- 00:01:22.893 and second, a customer 00:01:23.748 -- 00:01:25.851 that we were s...